Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early methylprednisolone in acute large artery occlusion stroke
ChiCTR2100051664Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in ischemic stroke (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: 90-day mRS score. Started Nov 2021; status: recruiting.
02
Drugs
methylprednisolone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100051664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051664.